No abstract

No abstract

þ2.2ml/s at 3 months (p<0.001) was not sustained and reduced to þ1.1ml/s at 12 months (p[0.06). Treatment failure was reported in n[3 (6%) patients. The duration of catheter insertion was (days) median 1 (range 0-6).CONCLUSIONS: This study demonstrates that ProstaCare is a safe treatment for BPH with sustained symptomatic improvement at 12 months follow up. Water electrolysis treatment of prostate can be considered as an alternative to the use of pharmaceutical medication.